In a 25-year-old woman with mild leukopenia, low‑normal absolute neutrophil count, borderline low absolute lymphocyte count, and mildly elevated mean corpuscular volume, what is the differential diagnosis and what laboratory studies and management steps should be pursued?

Workup and Management of Mild Leukopenia with Macrocytosis in a Young Woman

This 25-year-old woman has mild leukopenia (WBC 3.2) with borderline low absolute lymphocyte count (1.0) and elevated MCV (101 fL), which most likely represents either benign ethnic neutropenia, nutritional deficiency (B12/folate), autoimmune disease, or early bone marrow disorder—the priority is to exclude reversible causes and autoimmune conditions before considering bone marrow evaluation.

Key Laboratory Findings Analysis

The patient presents with:

• Mild leukopenia (WBC 3.2 × 10³/μL)
• Low-normal absolute neutrophil count (ANC 1.9 × 10³/μL)
• Borderline low absolute lymphocyte count (1.0 × 10³/μL)
• Elevated MCV (101 fL) with elevated MCH (33.6 pg)
• Normal hemoglobin (15.4 g/dL), hematocrit, and platelet count
• Normal RDW (13.7%)

The macrocytosis with normal hemoglobin is particularly important—this pattern suggests vitamin B12 or folate deficiency, autoimmune disease, thyroid dysfunction, or medication effect rather than acute bone marrow failure 1.

Differential Diagnosis (Prioritized by Likelihood)

1. Nutritional Deficiencies

The elevated MCV strongly suggests B12 or folate deficiency 1. Macrocytosis indicates vitamin deficiency and can occur with normal hemoglobin in early stages. The normal RDW argues against concurrent iron deficiency masking the macrocytosis 1.

2. Autoimmune/Autoinflammatory Disease

Autoimmunity is a leading cause of isolated leukopenia in young women 2. In one study, 53.8% of isolated leukopenia cases had autoimmune diagnosis or laboratory findings, with autoimmune thyroid disease and other autoimmune conditions being most common 2.

3. Benign Ethnic Neutropenia

If the patient is of African, Middle Eastern, or Arab descent, Duffy-null-associated neutrophil count (DANC) should be considered 3, 4. This is not a medical condition and affects 80-100% of Sub-Saharan Africans 3. However, the lymphopenia makes this less likely as the sole explanation.

4. Medication Effect

Various medications can cause macrocytosis and mild leukopenia 1, 2.

5. Early Bone Marrow Disorder

Less likely given normal hemoglobin and platelets, but cannot be excluded without further workup 5, 6.

Recommended Diagnostic Workup

Immediate Laboratory Studies (First-Line)

1. Vitamin B12 and folate levels 1—essential given the macrocytosis
2. Thyroid function tests (TSH, free T4) 1, 2—autoimmune thyroid disease is common in young women with leukopenia
3. Comprehensive metabolic panel including liver function tests
4. Reticulocyte count 1, 5—to assess bone marrow response
5. Peripheral blood smear review 7, 8—essential for detecting dysplasia, abnormal cells, or morphologic clues
6. Serum ferritin, transferrin saturation, and CRP 1—iron deficiency can coexist and is common in young women

Second-Line Studies (If Initial Workup Unrevealing)

1. Autoimmune serologies: ANA, anti-dsDNA, rheumatoid factor, anti-thyroid antibodies 2
2. HIV and hepatitis B/C screening 9—chronic viral infections cause leukopenia
3. LDH and haptoglobin 1—to exclude hemolysis
4. Duffy antigen phenotyping if patient is of appropriate ethnic background 3, 4

When to Pursue Bone Marrow Examination

Bone marrow aspiration and biopsy with cytogenetics should be considered if 7, 5, 7, 6:

• Leukopenia persists >3 months despite correction of reversible causes 3
• Progressive decline in counts
• Development of additional cytopenias
• Peripheral smear shows dysplasia or abnormal cells
• Unexplained symptoms (fever, night sweats, weight loss)
• ANC falls below 1.0 × 10³/μL

Important caveat: The current ANC of 1.9 × 10³/μL does NOT require immediate bone marrow examination unless other concerning features develop 6.

Management Algorithm

Step 1: Repeat CBC in 2-4 Weeks

Confirm persistence of abnormalities and assess for dynamic changes 3, 8. Review any previous blood counts to establish chronicity 8.

Step 2: Address Reversible Causes

• If B12 or folate deficient: Supplement appropriately and recheck CBC in 4-6 weeks
• If thyroid dysfunction: Treat and monitor response
• If medication-related: Consider discontinuation if medically appropriate
• If iron deficient: Supplement (common in young women) 2

Step 3: Monitor vs. Further Investigation

• If counts stable and patient asymptomatic: Monitor CBC every 3-6 months 3, 6
• If counts declining or new symptoms: Proceed to bone marrow examination 5, 6
• If autoimmune disease identified: Treat underlying condition and monitor hematologic response

Step 4: Infection Risk Assessment

With ANC 1.9 × 10³/μL, infection risk is minimal 6. No prophylactic antibiotics or growth factors needed. Educate patient to seek care promptly if fever develops, but routine precautions are sufficient.

Critical Clinical Pearls

The normal RDW is reassuring—it argues against significant iron deficiency and suggests a more uniform population of macrocytic cells rather than mixed deficiency 1, 10.

The isolated nature of the leukopenia matters—with normal hemoglobin and platelets, this is far less concerning than pancytopenia and suggests a more benign process 3, 2.

Young women are disproportionately affected by autoimmune causes—thyroid disease and other autoimmune conditions should be actively sought 2.

Avoid premature bone marrow examination—in the absence of severe neutropenia (ANC <1.0), progressive decline, or dysplasia on smear, bone marrow biopsy can be deferred pending results of less invasive testing 6, 9.

Clinical history trumps absolute numbers—management decisions should prioritize infection history and symptoms over neutrophil count alone 3, 6. This patient's lack of recurrent infections is reassuring.